NAUT logo

Nautilus Biotechnolgy, Inc.

NAUT
0.00
USD
+0.00+0.00%

Nautilus Biotechnolgy, Inc. at a glance

Open NAUT on Vela

Nautilus Biotechnolgy, Inc. (NAUT) is a Healthcare company in the Biotechnology industry, headquartered in Seattle, WA, with about 127 employees. Its shares trade on NASDAQ, and its IPO date is August 7, 2020. With a market capitalization of $412.3 million, NAUT is a small-cap stock.

It trades an average of 3.4 million shares a day.

In its latest reported quarter (results released July 28, 2026), Nautilus Biotechnolgy, Inc. posted revenue of $190,000 and earnings of -$0.11 per share, against estimates of $100,000 and -$0.14.

Figures as of October 26, 2026, from market data providers. Descriptive only, not financial advice.

NAUT: Frequently asked questions

As of October 26, 2026, Nautilus Biotechnolgy, Inc. has a market capitalization of $412.3 million, making it a small-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.